Poorest WTO members win new patent-rule waiver

Jun 11, 2013

The globe's poorest nations have won an eight-year extension of a waiver on intellectual property rules, but still need to hold talks on the vexed issue of pharmaceutical patents, World Trade Organization officials said Tuesday.

A session of the 159-nation WTO's TRIPS Council—standing for trade-related aspects of —ruled that the waiver for 34 countries can now run until July 1, 2021.

"The agreement reached by members makes very clear that we can come together and get things done," WTO chief Pascal Lamy told the council, saying that it provided valuable lessons as member states struggle to revive the so-called Doha Round of liberalisation talks.

The TRIPS agreement, in force since 1995, requires WTO member states to legislate and enforce minimum standards for the protection of intellectual property in order to boost confidence in global commerce.

But critics said that such rules would be tough to bring in and police in the world's poorest nations, whose failure to fall into line could thereby shut them out of trade sectors and hamper their development.

With the stated goal of the Doha Round, launched at a summit in Qatar in 2001, to harness to help boost , WTO members that year agreed on a waiver.

Initially due to run out in 2006, it was extended to 2013.

Separate rules within the TRIPS agreement apply to pharmaceuticals, where a current waiver runs out in 2016, meaning talks will be needed if the countries are to win a new extension.

The pharmaceutical rules within TRIPS are the focus of intense criticism from health campaigners, who charge that they make it tough for countries without a waiver to get access to affordable medicines and are seeking an open-ended escape clause for the poorest nations.

Explore further: Amazon launches 3D printing store

add to favorites email to friend print save as pdf

Related Stories

Bayer 'disappointed' after losing India patent fight

Sep 26, 2012

Pharmaceutical giant Bayer AG on Wednesday said it was "disappointed" with an Indian ruling that allows a local firm to produce a cheaper copy of its patented drug Nexavar for liver and lung cancer.

Bayer challenges India cancer drug ruling

May 06, 2012

German pharmaceutical giant Bayer AG has challenged a ground-breaking Indian ruling that allowed a local firm to produce a vastly cheaper copy of its patented drug for kidney and liver cancer.

WTO chief plays down China rare earth row

Mar 16, 2012

The head of the World Trade Organization on Friday played down a dispute over China's controls on exports of rare earth minerals, saying it was unlikely to escalate into a trade war.

Recommended for you

Chinese smartphone makers win as market swells

9 hours ago

Chinese smartphone makers racked up big gains as the global market for Internet-linked handsets grew to record levels in the second quarter, International Data Corp said Tuesday.

Full appeals court upholds labels on meat packages

9 hours ago

(AP)—A federal appeals court has upheld new government rules that require labels on packaged steaks, ribs and other cuts of meat to say where the animals were born, raised and slaughtered.

BlackBerry buys German anti-eavesdropping firm

9 hours ago

Canadian smartphone maker BlackBerry announced Tuesday the purchase of German voice and data encryption and anti-eavesdropping firm Secusmart, whose customers include NATO and German Chancellor Angela Merkel ...

India's Flipkart raises $1 bn to tackle Amazon

11 hours ago

India's top e-commerce company Flipkart said Tuesday it had raised $1 billion (60 billion rupees) in funds as it battles US giant Amazon for supremacy in the hyper-competitive local market.

User comments : 0